NT_1170x120_1-11-18

Mallinckrodt

Mallinckrodt to locate specialty business in N.J.

Mallinckrodt to locate specialty business in N.J.

CHESTERFIELD, United Kingdom — Mallinckrodt plc is building out a new campus in Bedminster, N.J., to house its rapidly growing specialty brands organizations. The drug maker said it plans to invest more than $80 million in New Jersey and expects about 400 employees to occupy the new space in the first quarter of 2017. The

Mallinckrodt joins National Pharmaceutical Council

Mallinckrodt joins National Pharmaceutical Council

WASHINGTON — Mallinckrodt Pharmaceuticals has become a member of the National Pharmaceutical Council (NPC). The health policy research organization said Thursday that Steven Romano, senior vice president and chief scientific officer at Mallinckrodt, will serve as the company’s representative on the NPC board of directors. “We are pleased that Mallinckrodt has joined us in support

Perrigo set to ship generic version of Exalgo

DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for hydromorphone HCI extended-release tablets (8 mg, 12 mg and 16 mg), an opioid pain medication. Perrigo said that it expects to begin shipments of the product to pharmacies within the next few weeks. The FDA concluded that Perrigo’s products